Tibet AIM Pharm. Inc. (SHE:002826)

Tibet AIM Pharm. Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 3, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	3,978	1,901	2,263	1,943	2,094	1,872
Market Cap Growth	109.27%	-16.02%	16.48%	-7.19%	11.85%	-4.18%
Enterprise Value	3,427	1,527	1,981	1,695	1,954	1,760
Last Close Price	21.24	10.32	11.78	10.02	10.66	9.42
PE Ratio	44.65	41.39	147.10	44.03	49.29	45.55
PS Ratio	6.33	2.92	3.39	2.27	2.89	3.11
PB Ratio	4.96	2.55	3.02	2.59	2.91	2.72
P/TBV Ratio	5.19	2.71	3.22	2.87	3.25	2.93
P/FCF Ratio	28.61	19.14	13.83	29.78	24.83	29.57
P/OCF Ratio	27.00	17.04	13.56	28.39	19.11	18.40
EV/Sales Ratio	5.46	2.34	2.97	1.98	2.69	2.92
EV/EBITDA Ratio	40.26	31.28	40.39	24.56	29.95	31.46
EV/EBIT Ratio	52.32	56.01	79.53	36.60	46.99	44.89
EV/FCF Ratio	24.65	15.37	12.10	25.98	23.17	27.80
Debt / Equity Ratio	0.03	0.03	0.02	0.07	-	0.06
Debt / EBITDA Ratio	0.31	0.47	0.22	0.73	-	0.71
Debt / FCF Ratio	0.19	0.23	0.07	0.77	-	0.63
Asset Turnover	0.62	0.70	0.69	0.93	0.84	0.69
Inventory Turnover	3.16	4.11	6.23	12.15	17.12	15.35
Quick Ratio	2.49	2.76	2.51	2.00	3.22	1.94
Current Ratio	2.67	3.01	2.86	2.19	3.65	2.06
Return on Equity (ROE)	11.24%	6.35%	2.10%	6.27%	6.18%	6.14%
Return on Assets (ROA)	4.07%	1.84%	1.60%	3.14%	3.00%	2.81%
Return on Invested Capital (ROIC)	18.39%	5.99%	3.89%	7.07%	6.82%	6.46%
Return on Capital Employed (ROCE)	8.10%	3.60%	3.30%	6.10%	5.70%	5.70%
Earnings Yield	2.16%	2.42%	0.68%	2.27%	2.03%	2.20%
FCF Yield	3.49%	5.23%	7.23%	3.36%	4.03%	3.38%
Dividend Yield	0.48%	0.97%	0.26%	1.00%	0.94%	0.85%
Payout Ratio	27.73%	13.14%	131.81%	44.78%	35.95%	18.67%
Buyback Yield / Dilution	8.40%	4.48%	-0.23%	0.61%	-3.37%	-0.07%
Total Shareholder Return	8.92%	5.45%	0.03%	1.61%	-2.43%	0.78%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.